Early response assessment in prostate carcinoma by 18F- fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 1, 2011, Pages 81-89

  Oyama, Nobuyuki ^a   Hasegawa, Yoko ^a   Kiyono, Yasushi ^a   Kobayashi, Masato ^a   Fujibayashi, Yasuhisa ^a   Ponde, Datta E ^b   Dence, Carmen ^b   Welch, Michael J ^b,c   Yokoyama, Osamu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MO   (United States)

Author keywords

Docetaxel; PET; Prostate cancer; Tumour proliferation

Indexed keywords

3' FLUOROTHYMIDINE F 18; DOCETAXEL; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; IMMUNOHISTOCHEMISTRY; INCUBATION TEMPERATURE; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROSTATE CARCINOMA; TREATMENT RESPONSE; TUMOR CELL LINE; TUMOR MODEL;

EID: 85027935817     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1613-z     Document Type: Article

References (29)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. C Huggins CV Hodges 1941 Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Res 1 293 297 1:CAS:528: DyaH3MXkvVCrtw%3D%3D
3. MA Eisenberger 1988 Chemotherapy for prostate carcinoma NCI Monogr 7 151 163 3050534
4. DP Petrylak CM Tangen MH Hussain PN Lara Jr JA Jones ME Taplin, et al. 2004 Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N Engl J Med 351 1513 1520 1:CAS:528:DC%2BD2cXot1Kmu7c%3D 10.1056/NEJMoa041318 15470214 (Pubitemid 39315318)
5. N Oyama J Kim LA Jones NM Mercer JA Engelbach TL Sharp, et al. 2002 MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model Nucl Med Biol 29 783 790 1:CAS:528:DC%2BD38XovFKjt78%3D 10.1016/S0969-8051(02)00346-3 12453586 (Pubitemid 35346897)
6. N Oyama H Akino Y Suzuki H Kanamaru H Ishida K Tanase, et al. 2001 FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation Nucl Med Commun 22 963 969 1:CAS:528:DC%2BD3MXmvFKrtL4%3D 10.1097/00006231-200109000-00004 11505204 (Pubitemid 32783446)
7. KA Kurdziel WD Figg JA Carrasquillo S Huebsch M Whatley D Sellers, et al. 2003 Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer Mol Imaging Biol 5 86 93 10.1016/S1536-1632(03)00039-8 14499149
8. PJ Effert R Bares S Handt JM Wolff D Büll G Jakse 1996 Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose J Urol 155 994 998 1:STN:280: DyaK287msVKnug%3D%3D 10.1016/S0022-5347(01)66366-3 8583625 (Pubitemid 26052696)
9. N Oyama H Akino Y Suzuki H Kanamaru N Sadato Y Yonekura, et al. 1999 The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer Jpn J Clin Oncol 29 623 629 1:STN:280:DC%2BD3c7osFShsg%3D%3D 10.1093/jjco/29.12.623 10721945
10. T Hara N Kosaka H Kishi 1998 PET imaging of prostate cancer using carbon-11-choline J Nucl Med 39 990 995 1:CAS:528:DyaK1cXktV2itrg%3D 9627331
11. TR DeGrado SW Baldwin S Wang MD Orr RP Liao HS Friedman, et al. 2001 Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers J Nucl Med 42 1805 1814 1:CAS:528:DC%2BD38XktlOktb8%3D 11752077
12. N Oyama H Akino H Kanamaru Y Suzuki S Muramoto Y Yonekura, et al. 2002 11C-acetate PET imaging of prostate cancer J Nucl Med 43 181 186 1:CAS:528:DC%2BD38XjvFWjtro%3D 11850482
13. M Yoshimoto A Waki Y Yonekura N Sadato T Murata N Omata, et al. 2001 Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells Nucl Med Biol 28 117 122 1:CAS:528:DC%2BD3MXisVWnt70%3D 10.1016/S0969-8051(00)00195-5 11295421 (Pubitemid 32276075)
14. M Yoshimoto A Waki A Obata T Furukawa Y Yonekura Y Fujibayashi 2004 Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate Nucl Med Biol 31 859 865 1:CAS:528:DC%2BD2cXotFClsr8%3D 10.1016/j.nucmedbio.2004.05.002 15464387 (Pubitemid 39297683)
15. AF Shields JR Grierson BM Dohmen HJ Machulla JC Stayanoff JM Lawhorn-Crews, et al. 1998 Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat Med 4 1334 1336 1:CAS:528:DyaK1cXntlaqsrk%3D 10.1038/3337 9809561 (Pubitemid 28512118)
16. AK Buck H Schirrmeister M Hetzel M Von Der Heide G Halter G Glatting, et al. 2002 3-Deoxy-3-[18F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules Cancer Res 62 3331 3334 1:CAS:528:DC%2BD38XkslWqs7k%3D 12067968
17. H Vesselle J Grierson M Muzi JM Pugsley RA Schmidt P Rabinowitz, et al. 2002 In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors Clin Cancer Res 8 3315 3323 1:CAS:528:DC%2BD38XpsVCgtr0%3D 12429617
18. BS Pio CK Park R Pietras WA Hsueh N Satyamurthy MD Pegram, et al. 2006 Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy Mol Imaging Biol 8 36 42 10.1007/s11307-005-0029-9 16362149 (Pubitemid 44201576)
19. Ponde DE, Oyama N, Welch MJ, McCarthy TJ. Synthesis of fluorothymidine ([18F]FLT) for radiotracer of tumors. Abstr Pap AM Chem S 2002;223:081-Nucl Part 2.
20. YC Tai A Chatziioannou S Siegel J Young D Newport RN Goble, et al. 2001 Performance evaluation of the microPET P4: a PET system dedicated to animal imaging Phys Med Biol 46 1845 1862 1:STN:280:DC%2BD38%2FisVCluw%3D%3D 10.1088/0031-9155/46/7/308 11474929 (Pubitemid 32677543)
21. AF Shields K Lim J Grierson J Link KA Krohn 1990 Utilization of labeled thymidine in DNA synthesis: studies for PET J Nucl Med 31 337 342 1:CAS:528:DyaK3cXksFGisLc%3D 2308005
22. P Goethals M van Eijkeren W Lodewyck R Dams 1995 Measurement of [methyl-carbon-11]thymidine and its metabolites in head and neck tumors J Nucl Med 36 880 882 1:STN:280:DyaK2M3ls12ruw%3D%3D 7738667
23. AF Shields DA Mankoff JM Link MM Graham JF Eary SM Kozawa, et al. 1998 Carbon-11-thymidine and FDG to measure therapy response J Nucl Med 39 1757 1762 1:CAS:528:DyaK1cXmvFGhu7w%3D 9776283
24. JM Wells DA Mankoff M Muzi F O'Sullivan JF Eary AM Spence, et al. 2002 Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis Mol Imaging 1 151 159 1:CAS:528:DC%2BD38XnsVCqtb0%3D 10.1162/153535002760235454 12920853
25. JS Rasey JR Grierson LW Wiens PD Kolb JL Schwartz 2002 Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells J Nucl Med 43 1210 1217 1:CAS:528:DC%2BD38Xns1elsrk%3D 12215561
26. H Dittmann BM Dohmen R Kehlbach G Bartusek M Pritzkow M Sarbia, et al. 2002 Early changes in [18F]FLT uptake after chemotherapy: an experimental study Eur J Nucl Med Mol Imaging 29 1462 1469 1:CAS:528:DC%2BD38XotV2isbY%3D 10.1007/s00259-002-0925-z 12397465 (Pubitemid 35232048)
27. T Ebenhan M Honer SM Ametamey PA Schubiger M Becquet S Ferretti, et al. 2009 Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone Mol Imaging Biol 11 308 321 1:STN:280:DC%2BD1Mris1aitQ%3D%3D 10.1007/s11307-009-0216-1 19462209
28. KH Altmann 2003 Epothilone B and its analogs - a new family of anticancer agents Mini Rev Med Chem 3 149 158 1:CAS:528:DC%2BD3sXht12qu7c%3D 10.2174/1389557033405269 12570848
29. J Yue L Chen AR Cabrera X Sun S Zhao F Zheng, et al. 2010 Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study J Nucl Med 51 528 534 10.2967/jnumed.109.072124 20237030